194 related articles for article (PubMed ID: 2824652)
1. Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity.
McNearney TA; Odell C; Holers VM; Spear PG; Atkinson JP
J Exp Med; 1987 Nov; 166(5):1525-35. PubMed ID: 2824652
[TBL] [Abstract][Full Text] [Related]
2. Herpes simplex virus glycoprotein C: molecular mimicry of complement regulatory proteins by a viral protein.
Huemer HP; Wang Y; Garred P; Koistinen V; Oppermann S
Immunology; 1993 Aug; 79(4):639-47. PubMed ID: 8406590
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing the interaction of herpes simplex virus glycoprotein C with the third component of complement.
Huemer HP; Larcher C; Dierich MP; Falke D
Arch Virol; 1992; 127(1-4):291-303. PubMed ID: 1333754
[TBL] [Abstract][Full Text] [Related]
4. The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway.
Hung SL; Peng C; Kostavasili I; Friedman HM; Lambris JD; Eisenberg RJ; Cohen GH
Virology; 1994 Sep; 203(2):299-312. PubMed ID: 8053154
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
[TBL] [Abstract][Full Text] [Related]
6. Binding of complement component C3b to glycoprotein gC of herpes simplex virus type 1: mapping of gC-binding sites and demonstration of conserved C3b binding in low-passage clinical isolates.
Friedman HM; Glorioso JC; Cohen GH; Hastings JC; Harris SL; Eisenberg RJ
J Virol; 1986 Nov; 60(2):470-5. PubMed ID: 3021981
[TBL] [Abstract][Full Text] [Related]
7. Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells.
Friedman HM; Cohen GH; Eisenberg RJ; Seidel CA; Cines DB
Nature; 1984 Jun 14-20; 309(5969):633-5. PubMed ID: 6328323
[TBL] [Abstract][Full Text] [Related]
8. Complement component C3b binds directly to purified glycoprotein C of herpes simplex virus types 1 and 2.
Eisenberg RJ; Ponce de Leon M; Friedman HM; Fries LF; Frank MM; Hastings JC; Cohen GH
Microb Pathog; 1987 Dec; 3(6):423-35. PubMed ID: 2849025
[TBL] [Abstract][Full Text] [Related]
9. Herpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibody.
Hook LM; Lubinski JM; Jiang M; Pangburn MK; Friedman HM
J Virol; 2006 Apr; 80(8):4038-46. PubMed ID: 16571820
[TBL] [Abstract][Full Text] [Related]
10. Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b.
Rux AH; Lou H; Lambris JD; Friedman HM; Eisenberg RJ; Cohen GH
Virology; 2002 Mar; 294(2):324-32. PubMed ID: 12009874
[TBL] [Abstract][Full Text] [Related]
11. Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccine.
Awasthi S; Lubinski JM; Friedman HM
Vaccine; 2009 Nov; 27(49):6845-53. PubMed ID: 19761834
[TBL] [Abstract][Full Text] [Related]
12. Immune evasion properties of herpes simplex virus type 1 glycoprotein gC.
Friedman HM; Wang L; Fishman NO; Lambris JD; Eisenberg RJ; Cohen GH; Lubinski J
J Virol; 1996 Jul; 70(7):4253-60. PubMed ID: 8676446
[TBL] [Abstract][Full Text] [Related]
13. Glycoprotein C of herpes simplex virus type 1 is essential for the virus to evade antibody-independent complement-mediated virus inactivation and lysis of virus-infected cells.
Hidaka Y; Sakai Y; Toh Y; Mori R
J Gen Virol; 1991 Apr; 72 ( Pt 4)():915-21. PubMed ID: 1849974
[TBL] [Abstract][Full Text] [Related]
14. Glycoprotein C of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization.
Harris SL; Frank I; Yee A; Cohen GH; Eisenberg RJ; Friedman HM
J Infect Dis; 1990 Aug; 162(2):331-7. PubMed ID: 2165106
[TBL] [Abstract][Full Text] [Related]
15. Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.
Nemerow GR; Jensen FC; Cooper NR
J Clin Invest; 1982 Nov; 70(5):1081-91. PubMed ID: 6290536
[TBL] [Abstract][Full Text] [Related]
16. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
[TBL] [Abstract][Full Text] [Related]
17. C3b receptor activity on transfected cells expressing glycoprotein C of herpes simplex virus types 1 and 2.
Seidel-Dugan C; Ponce de Leon M; Friedman HM; Fries LF; Frank MM; Cohen GH; Eisenberg RJ
J Virol; 1988 Nov; 62(11):4027-36. PubMed ID: 2845122
[TBL] [Abstract][Full Text] [Related]
18. Binding of complement component C3b to glycoprotein C is modulated by sialic acid on herpes simplex virus type 1-infected cells.
Smiley ML; Friedman HM
J Virol; 1985 Sep; 55(3):857-61. PubMed ID: 2991604
[TBL] [Abstract][Full Text] [Related]
19. Novel mechanism of antibody-independent complement neutralization of herpes simplex virus type 1.
Friedman HM; Wang L; Pangburn MK; Lambris JD; Lubinski J
J Immunol; 2000 Oct; 165(8):4528-36. PubMed ID: 11035093
[TBL] [Abstract][Full Text] [Related]
20. Implications for herpes simplex virus vaccine strategies based on antibodies produced to herpes simplex virus type 1 glycoprotein gC immune evasion domains.
Chang YJ; Jiang M; Lubinski JM; King RD; Friedman HM
Vaccine; 2005 Sep; 23(38):4658-65. PubMed ID: 15936852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
